Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria A S Broggi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Visualized Experiments : Jove|August 23, 2014
Transplantation of tail skin to study allogeneic CD4 T cell responses in miceMathias Schmaler, Maria A S Broggi, Simona W Rossi
Journal of Visualized Experiments : Jove|September 2, 2014
Isolation of murine lymph node stromal cellsMaria A S Broggi, Mathias Schmaler, Nadège Lagarde, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2015
IL-7R signaling in regulatory T cells maintains peripheral and allograft tolerance in miceMathias Schmaler, Maria A S Broggi, Nadège Lagarde, et al.
The Journal of Experimental Medicine|April 13, 2019
Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patientsMaria A S Broggi, Lea Maillat, Cristina C Clement, et al.
Nature Materials|January 16, 2019
Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunityD Scott Wilson, Sachiko Hirosue, Michal M Raczy, et al.
Science Translational Medicine|September 15, 2017
Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanomaManuel Fankhauser, Maria A S Broggi, Lambert Potin, et al.
Molecular Therapy. Oncology|April 10, 2024
Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus encoding IL-12Cheyne Kurokawa, Sonia Agrawal, Abhisek Mitra, et al.
Oncoimmunology|September 18, 2018
Lymphatic vessel density is associated with CD8Natacha Bordry, Maria A S Broggi, Kaat de Jonge, et al.
Journal for Immunotherapy of Cancer|August 4, 2025
An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine releaseMiguel Gaspar, Marina Natoli, Laure Castan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2024
Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal CancersAllison M Barrett, Zachary T Britton, Rosa A Carrasco, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Visualized Experiments : Jove|August 23, 2014
Transplantation of tail skin to study allogeneic CD4 T cell responses in miceMathias Schmaler, Maria A S Broggi, Simona W Rossi
Journal of Visualized Experiments : Jove|September 2, 2014
Isolation of murine lymph node stromal cellsMaria A S Broggi, Mathias Schmaler, Nadège Lagarde, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2015
IL-7R signaling in regulatory T cells maintains peripheral and allograft tolerance in miceMathias Schmaler, Maria A S Broggi, Nadège Lagarde, et al.
The Journal of Experimental Medicine|April 13, 2019
Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patientsMaria A S Broggi, Lea Maillat, Cristina C Clement, et al.
Nature Materials|January 16, 2019
Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunityD Scott Wilson, Sachiko Hirosue, Michal M Raczy, et al.
Science Translational Medicine|September 15, 2017
Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanomaManuel Fankhauser, Maria A S Broggi, Lambert Potin, et al.
Molecular Therapy. Oncology|April 10, 2024
Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus encoding IL-12Cheyne Kurokawa, Sonia Agrawal, Abhisek Mitra, et al.
Oncoimmunology|September 18, 2018
Lymphatic vessel density is associated with CD8Natacha Bordry, Maria A S Broggi, Kaat de Jonge, et al.
Journal for Immunotherapy of Cancer|August 4, 2025
An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine releaseMiguel Gaspar, Marina Natoli, Laure Castan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2024
Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal CancersAllison M Barrett, Zachary T Britton, Rosa A Carrasco, et al.
Pageof 1